Related Experiment Video
Updated: Aug 5, 2025

09:45
Detection of Copy Number Alterations Using Single Cell Sequencing
Published on: February 17, 2017
11.7K
rcCAE: a convolutional autoencoder method for detecting intra-tumor heterogeneity and single-cell copy number
Zhenhua Yu1,2, Furui Liu1, Fangyuan Shi1,2
1School of Information Engineering, Ningxia University, 750021, Ningxia, China.
Briefings in Bioinformatics
|March 24, 2023
Summary
Intra-tumor heterogeneity (ITH) drives cancer relapse. Our new method, rcCAE, uses single-cell DNA sequencing to accurately identify cell subpopulations and copy number alterations, improving personalized cancer therapy.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Intra-tumor heterogeneity (ITH) is a key challenge in cancer, leading to relapse and treatment resistance.
- Single-cell DNA sequencing (scDNA-seq) offers high resolution for studying ITH by profiling copy number alterations (CNAs) at the single-cell level.
Purpose of the Study:
- To introduce rcCAE, an integrated framework for accurate inference of cell subpopulations and single-cell CNAs from scDNA-seq data.
- To enhance the understanding of ITH for improved personalized cancer therapies.
Main Methods:
- Utilized a convolutional autoencoder (CAE) within rcCAE to learn latent cell representations and extract CNA information from noisy scDNA-seq read counts.
- Employed unsupervised representation learning for accurate cell clustering in a low-dimensional latent space.
- Developed methods for detecting single-cell CNAs from enhanced read count data.
Main Results:
- rcCAE demonstrated superior performance compared to existing CNA calling methods on simulated datasets.
- The framework proved highly effective in inferring cancer clonal architecture.
- Analysis of real datasets revealed a more refined clonal structure, capturing details missed by integer copy number-based methods.
Conclusions:
- rcCAE provides a robust and accurate approach for deciphering ITH from scDNA-seq data.
- The method offers a more granular view of clonal evolution, crucial for advancing personalized cancer treatment strategies.

